0|chunk|Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency Disease
0	185	217 Primary Immunodeficiency Disease	Disease	DOID_612
0	210	217 Disease	Disease	DOID_4

1|chunk|Purpose Immune globulins for IgG supplementation have been produced for over 35 years with essentially no differentiating features regarding their specific antibody composition.

